Related Experiment Video
Updated: May 20, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic
Judith Fillaux1, François Brémont, Marléne Murris
1Service de Parasitologie-Mycologie, CHU Rangueil, Toulouse, France. fillaux.j@chu-toulouse.fr
Background:
Cystic fibrosis (CF) patients presenting with persistent carriage of, or sensitization to, Aspergillus fumigatus are often treated with antifungal therapies because the presence of the fungus is commonly thought to impede lung function, even in the absence of allergic bronchopulmonary aspergillosis (ABPA). The aim of this study was to assess Aspergillus-related status modulating the forced expiratory volume in 1 s (FEV₁) of CF patients.
Methods:
From 1995 to 2007, 251 patients were evaluated. Demographic data, cystic fibrosis transmembrane conductance regulator gene (CFTR) mutations, body mass index, and FEV(1) were recorded. The presence of A. fumigatus and Pseudomonas aeruginosa in sputum and the levels of A. fumigatus precipitin, total IgE (t-IgE), and specific anti-A. fumigatus IgE (Af-IgE) were determined. Patients were divided into 3 groups: (1) ABPA: A. fumigatus precipitin ≥3 lines, Af-IgE > 0.35 IU/ml, and t-IgE ≥500 IU/ml; (2) sensitization: Af-IgE > 0.35 IU/ml but t-IgE < 500 IU/ml; and (3) persistent carriage: Af-IgE ≤ 0.35 IU/ml with either an A. fumigatus persistent positive culture or an A. fumigatus precipitin ≥3 lines, provided this serological finding had been found associated with at least 1 A. fumigatus-positive culture. The remaining patients represented the control group. A multivariate analysis was carried out with FEV(1) as the outcome variable.
Results:
ABPA, sensitization, and persistent carriage were significantly associated with a larger decline in FEV₁ compared with the control group, with odds ratios of 15.9, 14.9, and 10.7, respectively. This association was independent of other associated factors (P. aeruginosa transient detection, age, being underweight, and low FEV₁ at baseline).
Conclusions:
In addition to ABPA, sensitization and persistent carriage appear to have an impact on pulmonary function in CF patients.
Insights
Cystic fibrosis patients with Aspergillus fumigatus sensitization or persistent carriage experience worse lung function decline. This impact is significant even without allergic bronchopulmonary aspergillosis (ABPA).
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Genetics
Background:
- Cystic fibrosis (CF) patients with Aspergillus fumigatus carriage or sensitization are often treated with antifungals.
- Fungal presence is believed to impair lung function in CF, even without allergic bronchopulmonary aspergillosis (ABPA).
- This study investigates the impact of Aspergillus-related status on CF lung function.
Purpose of the Study:
- To assess how Aspergillus-related status influences forced expiratory volume in 1 second (FEV₁) in CF patients.
- To determine if sensitization or persistent carriage of Aspergillus fumigatus affects lung function independently of ABPA.
Main Methods:
- Evaluated 251 CF patients from 1995-2007, recording demographics, CFTR mutations, BMI, and FEV₁.
- Assessed A. fumigatus and Pseudomonas aeruginosa in sputum, and levels of A. fumigatus precipitin, total IgE, and specific anti-A. fumigatus IgE.
- Categorized patients into ABPA, sensitization, persistent carriage, and control groups for multivariate analysis of FEV₁.
Main Results:
- ABPA, sensitization, and persistent carriage were significantly associated with greater FEV₁ decline (ORs 15.9, 14.9, 10.7, respectively) compared to controls.
- These associations remained significant and independent of other factors like P. aeruginosa detection, age, BMI, and baseline FEV₁.
- The findings highlight a substantial negative impact of Aspergillus fumigatus on lung function in CF.
Conclusions:
- Aspergillus fumigatus sensitization and persistent carriage significantly impact pulmonary function in cystic fibrosis patients.
- These conditions, alongside ABPA, contribute to lung function decline in CF.
- Further research and clinical attention are warranted for these Aspergillus-related conditions in CF management.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Fungal Phylum Ascomycota
